Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8% – Here’s Why

Emerald Health Therapeutics, Inc. (CVE:EMH) shares were down 3.8% during trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Stock Down 3.8%

The company’s 50-day moving average price is C$0.26 and its 200 day moving average price is C$0.26. The stock has a market capitalization of C$52.28 million and a P/E ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97.

Emerald Health Therapeutics Company Profile

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.